Table of Contents
Preface
Chapter 1. Monoclonal Antibody Development Technology for Important Human Diseases
Linlin Zhai and Chenguang Shen
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of China
Chapter 2. Delivery and Therapeutic Application of Neutralizing Antibodies
Qi Li¹, Haonan Xing², Aiping Zheng², Yuanyu Huang¹, and Mei Lu¹
¹Advanced Research Institute of Multidisciplinary Science, School of Life Science, School of Medical Technology, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Beijing Institute of Technology, Zhongguancun, Beijing, China
²State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China
Chapter 3. Neutralizing Antibodies against Enterovirus: Recent Advances and Future Challenges Longfa Xu, Rui Zhu, and Tong Cheng
State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, PR China; Xiang An Biomedicine Laboratory, Xiamen, China; Research Unit of Frontier Technology of Structural Vaccinology, Chinese Academy of Medical Sciences, Xiamen Fujian, China
Chapter 4. Neutralizing Antibodies against Herpesvirus Entry Complex and Fusogen Ling Zhong¹,², Wanlin Zhang¹,², Claude Krummenacher³, Qinjian Zhao¹, and Xiao Zhang¹
¹College of Pharmacy, Chongqing Medical University, Chongqing, PR China ²State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, PR China
³Department of Biological and Biomedical Sciences, Rowan University, Glassboro, NJ, USA
Chapter 5. Recent Advances in Hepatitis Virus Neutralizing Antibody Research Mengyuan Zhao and Minghui Yang
School of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, Beijing, People’s Republic of China
Chapter 6. Research Progress on Neutralizing Antibodies against Orthopoxvirus: Insights for Monkeypox Prevention and Treatment Mengjun Li and Chenguang Shen
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of China
Chapter 7. Development of Anti-SARS-CoV-2 Neutralizing Antibodies Yushan Jiang, Zihan He, Zhuolin Li, and Chenguang Shen
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of China
Chapter 8. A Possible Treatment Option for COVID-19: The Inflammatory Factor Antibodies Jiayang Wang and Chenguang Shen
BSL-3 Laboratory (Guangdong), Guangdong Provincial Key Laboratory of Tropical Disease Research, School of Public Health, Southern Medical University, Guangzhou, People’s Republic of China
Chapter 9. Nanobodies in Human Infectious Diseases: A Comprehensive Review of Research and Applications Ziyou Chen¹,², Yuanzhi Chen¹,², Zhiren Zeng¹,², Na Yuan¹,², Yaxian Mei¹,³, Zhenzhen Zhu¹,², and Wenxin Luo¹,²
¹State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics; National Institute of Diagnostics and Vaccine, Development in Infectious Diseases, School of Public Health, School of Life Sciences, Xiamen University, Xiamen, China
²Xiang Na Biomedicine Laboratory, Xiamen, China ³Brand Innovation Department, Hangzhou Innovax Biotech Co. Ltd, Hangzhou, Zhejiang, China
Index

